{
  "id": [
    "31634460"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "31634460"
  ],
  "pmcid": [
    "PMC7173238"
  ],
  "doi": [
    "10.1016/j.ejphar.2019.172747"
  ],
  "title": [
    "Selected nucleos(t)ide-based prescribed drugs and their multi-target activity."
  ],
  "authorString": [
    "Pastuch-Gawołek G, Gillner D, Król E, Walczak K, Wandzik I."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Pastuch-Gawołek G"
          ],
          "firstName": [
            "Gabriela"
          ],
          "lastName": [
            "Pastuch-Gawołek"
          ],
          "initials": [
            "G"
          ],
          "authorId": [
            {
              "_": "0000-0001-8753-1143",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego 8, 44-100, Gliwice, Poland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Gillner D"
          ],
          "firstName": [
            "Danuta"
          ],
          "lastName": [
            "Gillner"
          ],
          "initials": [
            "D"
          ],
          "authorId": [
            {
              "_": "0000-0001-7187-2453",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego 8, 44-100, Gliwice, Poland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Król E"
          ],
          "firstName": [
            "Ewelina"
          ],
          "lastName": [
            "Król"
          ],
          "initials": [
            "E"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307, Gdansk, Poland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Walczak K"
          ],
          "firstName": [
            "Krzysztof"
          ],
          "lastName": [
            "Walczak"
          ],
          "initials": [
            "K"
          ],
          "authorId": [
            {
              "_": "0000-0001-8511-2009",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100, Gliwice, Poland."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Wandzik I"
          ],
          "firstName": [
            "Ilona"
          ],
          "lastName": [
            "Wandzik"
          ],
          "initials": [
            "I"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego 8, 44-100, Gliwice, Poland. Electronic address: Ilona.Wandzik@polsl.pl."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-8753-1143",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0001-7187-2453",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0001-8511-2009",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "865"
      ],
      "journalIssueId": [
        "2889948"
      ],
      "dateOfPublication": [
        "2019 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2019"
      ],
      "printPublicationDate": [
        "2019-12-01"
      ],
      "journal": [
        {
          "title": [
            "European journal of pharmacology"
          ],
          "ISOAbbreviation": [
            "Eur. J. Pharmacol."
          ],
          "medlineAbbreviation": [
            "Eur J Pharmacol"
          ],
          "NLMid": [
            "1254354"
          ],
          "ISSN": [
            "0014-2999"
          ],
          "ESSN": [
            "1879-0712"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2019"
  ],
  "pageInfo": [
    "172747"
  ],
  "abstractText": [
    "Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites-approved antineoplastic agents-that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains."
  ],
  "affiliation": [
    "Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Faculty of Chemistry, Silesian University of Technology, Krzywoustego 4, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego 8, 44-100, Gliwice, Poland."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Nucleosides"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Nucleotides"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Drug Prescriptions"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Molecular Targeted Therapy"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "MT"
                  ],
                  "qualifierName": [
                    "methods"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Antineoplastic agents",
        "Nucleotides",
        "Nucleosides",
        "Prodrugs",
        "Antiviral Therapy",
        "Chain Termination"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Nucleosides"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Nucleotides"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.ejphar.2019.172747"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7173238"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7173238?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1016/j.ejphar.2019.172747"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCompletion": [
    "2020-04-22"
  ],
  "dateOfCreation": [
    "2019-10-22"
  ],
  "firstIndexDate": [
    "2019-10-22"
  ],
  "fullTextReceivedDate": [
    "2020-04-24"
  ],
  "dateOfRevision": [
    "2020-04-23"
  ],
  "electronicPublicationDate": [
    "2019-10-18"
  ],
  "firstPublicationDate": [
    "2019-10-18"
  ]
}